The P2X7−/− mice, which showed no fibrotic changes under BLM treatment, had a high constitutive expression of GSK-3β(Ser9) [12], which is an indication of the protective effect of GSK-3β inhibition. This evidence concerns the gene GSK3B and Bloom syndrome.